الأعمال والاقتصاد
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
المصدر: Business News · نُشر
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
أخبار ذات صلة
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.
Business News ·
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
Business News ·
Autonomous trucking company Aurora looks to accelerate toward profitability
Aurora's founder and CEO told CNBC the company is targeting positive free cash flow by 2028, driven by a substantial increase in the number autonomous trucks.
Business News ·
Lowe's is launching a drone delivery service in partnership with DoorDash, Alphabet
Lowe's is launching a drone delivery service in a partnership with DoorDash and Alphabet's Wing, CNBC has learned exclusively.
Business News ·
Automattic has a new board after failed attempt to put CEO on leave
After days of upheaval at Automattic, following a failed attempt to remove CEO Matt Mullenweg, the company has a new board.
TechCrunch ·